drugset / Trial / NCT00702117

Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias

NCT00702117

Phase 4 Completed 123 enrolled Hospital Clinic of Barcelona
RandomizedParallel-groupOpen-labelTreatment

Summary

The study evaluates 3 different populations: It is an open, randomized, parallel-group study comparing the effectiveness of intravenous (iv) ajmaline with currently used antiarrhythmic drugs in the acute treatment of : 1. recent-onset atrial fibrillation versus iv flecainide 2. sustained monomorphous ventricular tachycardia versus iv procainamide The study also evaluates in an open, randomized, crossover study, the use of iv ajmaline versus iv flecainide in the diagnosis of Brugada syndrome

Timeline

Start
2008-06
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ajmaline Small molecule 1 mg/kg Intravenous
Comparator Procainamide Small molecule 10 mg/kg Intravenous
Comparator flecainide Small molecule 2 mg/kg Intravenous